MYC and diffuse large B-cell lymphoma: Although E1412 did not require COO determination or MYC FISH in RT to initiate therapy, having these data up-front is likely to be critical for future DLBCL trials, further underscoring the need for rapid, RT-ECPR and testing in the era of targeted therapy and precision medicine.